{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:28:33Z","timestamp":1772782113850,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.intimp.2022.109408","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T12:26:58Z","timestamp":1667996818000},"page":"109408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-8741","authenticated-orcid":false,"given":"Hao","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShuLin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongchao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leisheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109408_b0005","article-title":"Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management","volume":"8","author":"Khanam","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.intimp.2022.109408_b0010","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/stem.1818","article-title":"Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis","volume":"32","author":"Volarevic","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2022.109408_b0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1574888X15666200101124317","article-title":"A Brief Analysis of Mesenchymal Stem Cells as Biological Drugs for the Treatment of Acute-on-Chronic Liver Failure (ACLF): Safety and Potency","volume":"15","author":"Feng","year":"2020","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2022.109408_b0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"Shi","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.intimp.2022.109408_b0025","unstructured":"Y. Zheng, S. Zhu, X. Zheng, W. Xu, X. Li, J. Li, Z. Gao, C. Xie, L. Peng, Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells, J. Clin. Transl. Hepatol. 9 (2021) 503-513. 10.14218\/JCTH.2021.00014."},{"key":"10.1016\/j.intimp.2022.109408_b0030","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1002\/jcb.26772","article-title":"Bone marrow or adipose tissue mesenchymal stem cells: Comparison of the therapeutic potentials in mice model of acute liver failure","volume":"119","author":"Zare","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2022.109408_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173263","article-title":"Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis","volume":"882","author":"Mazhari","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109408_b0040","first-page":"107","article-title":"Hepatoprotective effect of bone marrow-derived mesenchymal stromal cells in CCl4-induced liver cirrhosis, 3","volume":"11","author":"Aithal","year":"2021","journal-title":"Biotech"},{"key":"10.1016\/j.intimp.2022.109408_b0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bj.2020.04.011","article-title":"Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis","volume":"44","author":"Khalil","year":"2021","journal-title":"Biomed. J."},{"key":"10.1016\/j.intimp.2022.109408_b0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s13287-019-1478-4","article-title":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease","volume":"10","author":"Zhao","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2022.109408_b0055","article-title":"Quality control and therapeutic investigations of mesenchymal stem\/stromal cells during investigational new drug application for GvHD administration in China","author":"Wang","year":"2022","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2022.109408_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2015.02.019","article-title":"Mesenchymal cell contributions to the stem cell niche","volume":"16","author":"Kfoury","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.intimp.2022.109408_b0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jmbbm.2017.01.038","article-title":"Is there a cause-and-effect relationship between physicochemical properties and cell behavior of alginate-based hydrogel obtained after sterilization?","volume":"68","author":"Yu","year":"2017","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.intimp.2022.109408_b0070","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s12015-020-10053-2","article-title":"Spatio-Temporal Stem\/Stromal Cells on Mice with Refractory Crohn's-like Enterocutaneous Fistula","volume":"16","author":"Hou","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.intimp.2022.109408_b0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13287-022-02805-3","article-title":"Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice","volume":"13","author":"Huang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2022.109408_b0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13287-021-02222-y","article-title":"Human umbilical cord-derived mesenchymal stem\/stromal cells: a promising candidate for the development of advanced therapy medicinal products","volume":"12","author":"Mebarki","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2022.109408_b0085","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/sctm.21-0083","article-title":"Development and investigational new drug application of mesenchymal stem\/stromal cells products in China","volume":"10","author":"Zhao","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.intimp.2022.109408_b0090","doi-asserted-by":"crossref","first-page":"3038565","DOI":"10.1155\/2018\/3038565","article-title":"Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production","volume":"2018","author":"Vigano","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.intimp.2022.109408_b0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ymthe.2004.02.022","article-title":"The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells","volume":"9","author":"Niyibizi","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2022.109408_b0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.intimp.2022.109408_b0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/sctm.17-0209","article-title":"Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem\/Stromal Cells","volume":"7","author":"Brooks","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.intimp.2022.109408_b0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41419-018-1239-9","article-title":"Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2022.109408_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.121.000607","article-title":"Define Mesenchymal Stem Cell from Its Fate: Biodisposition of Human Mesenchymal Stem Cells in Normal and Concanavalin A-Induced Liver Injury Mice","volume":"379","author":"Han","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2022.109408_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2018.04.020","article-title":"In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model","volume":"279","author":"Oh","year":"2018","journal-title":"J. Control. Release"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200892X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692200892X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:46:54Z","timestamp":1761587214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692200892X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S156757692200892X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109408","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109408"}}